Journal of Clinical Microbiology
Geisel School of Medicine
During a nosocomial hepatitis C outbreak, emergency public clinics employed the OraQuick HCV rapid antibody test on site, and all results were verified by a standard enzyme immunoassay (EIA). Of 1,157 persons, 1,149 (99.3%) exhibited concordant results between the two tests (16 positive, 1,133 negative). The sensitivity, specificity, positive predictive value, and negative predictive value were 94.1%, 99.5%, 72.7%, and 99.9%, respectively. OraQuick performed well as a screening test during an outbreak investigation and could be integrated into future hepatitis C virus (HCV) outbreak testing algorithms.
Dartmouth Digital Commons Citation
Gao, Fengxiang; Talbot, Elizabeth A.; Loring, Carol H.; Power, Jill J.; and Dionne-Odom, Jodie, "Performance of the OraQuick HCV Rapid Antibody Test for Screening Exposed Patients in a Hepatitis C Outbreak Investigation" (2014). Dartmouth Scholarship. 1301.